glp-1 parkinson's disease A New Treatment Strategy for through the Gut–Brain Axis: The Glucagon-Like Peptide-1 Receptor Pathway New study seeks to unlock

Description

Medical Weight Loss for Seniors: Tips and Considerations Gewichtsverlies kan op elke leeftijd uitdagend zijn, maar voor senioren komen er specifieke overwegingen kijken bij het kiezen van de juiste aanpak

Note: Retatrutide 10mg is strictly for research purposes and is not intended for human or veterinary use

What are GLP-1 medications and how do they work Medically reviewed by Dr Sultan Linjawi, Endocrinologist & Diabetes Specialist January 2026 GLP-1 medications have become some of the most talked-about treatments in type 2 diabetes and for good reason

Featured Publications Aug 2021 The Journal of Clinical Endocrinology & Metabolism PREVENT: A Randomized, Placebo-Controlled Crossover Trial of Avexitide for Treatment of Postbariatric Hypoglycemia Read more (opens new window) Aug 2020 Diabetes, Obesity and Metabolism Safety, Efficacy and Pharmacokinetics of Repeat Subcutaneous Dosing of Avexitide (Exendin 9-39) for Treatment of Post-Bariatric Hypoglycaemia Read more (opens new window) Feb 2018 Diabetes, Obesity and Metabolism Efficacy and Pharmacokinetics of Subcutaneous Exendin (9-39) in Patients with Post-Bariatric Hypoglycaemia Read more (opens new window) Sep 2008 Metabolism and Bioenergetics Exendin-(939) Corrects Fasting Hypoglycemia in SUR-1/ Mice by Lowering cAMP in Pancreatic -Cells and Inhibiting Insulin Secretion Read more (opens new window) Nov 1993 Diabetes Cloning and Functional Expression of the Human Islet GLP-1 Receptor: Demonstration That Exendin-4 Is an Agonist and Exendin-(939) an Antagonist of the Receptor Read more (opens new window) Next Subscribe to our news To stay up to date on Amylyx corporate updates, join our email list.